Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael G Amado

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Topics in Microbiology and Immunology|August 31, 2011
Predictive genomic biomarkersRakesh Kumar, Rafael G Amado
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trialsMichael Hedenus, Johan Vansteenkiste, Dusan Kotasek, et al.
Nature Biotechnology|October 9, 2007
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic miceAya Jakobovits, Rafael G Amado, Xiaodong Yang, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDSFrances K Ngok, Ronald T Mitsuyasu, Janet L Macpherson, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocolMaureen P Boyd, Frances K Ngok, Alison V Todd, et al.
Journal of the National Cancer Institute|February 16, 2006
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemiaJean-Luc Canon, Johan Vansteenkiste, György Bodoky, et al.
Clinical Colorectal Cancer|May 29, 2007
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancerJordan Berlin, James Posey, Simon Tchekmedyian, et al.
AJR. American Journal of Roentgenology|November 26, 2009
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patientsAntoinette S Gomes, Michael H Rosove, Peter J Rosen, et al.
Cancer|August 3, 2007
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancerJ Randolph Hecht, Amita Patnaik, Jordan Berlin, et al.
Cancer|February 4, 2009
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapyMarc Peeters, Salvatore Siena, Eric Van Cutsem, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Topics in Microbiology and Immunology|August 31, 2011
Predictive genomic biomarkersRakesh Kumar, Rafael G Amado
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trialsMichael Hedenus, Johan Vansteenkiste, Dusan Kotasek, et al.
Nature Biotechnology|October 9, 2007
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic miceAya Jakobovits, Rafael G Amado, Xiaodong Yang, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDSFrances K Ngok, Ronald T Mitsuyasu, Janet L Macpherson, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocolMaureen P Boyd, Frances K Ngok, Alison V Todd, et al.
Journal of the National Cancer Institute|February 16, 2006
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemiaJean-Luc Canon, Johan Vansteenkiste, György Bodoky, et al.
Clinical Colorectal Cancer|May 29, 2007
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancerJordan Berlin, James Posey, Simon Tchekmedyian, et al.
AJR. American Journal of Roentgenology|November 26, 2009
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patientsAntoinette S Gomes, Michael H Rosove, Peter J Rosen, et al.
Cancer|August 3, 2007
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancerJ Randolph Hecht, Amita Patnaik, Jordan Berlin, et al.
Cancer|February 4, 2009
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapyMarc Peeters, Salvatore Siena, Eric Van Cutsem, et al.
Pageof 3